BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30537129)

  • 1. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: A new look at hallmarks of breast cancer.
    Abdollahzadeh R; Daraei A; Mansoori Y; Sepahvand M; Amoli MM; Tavakkoly-Bazzaz J
    J Cell Physiol; 2019 Jul; 234(7):10080-10100. PubMed ID: 30537129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.
    Rahnama S; Bakhshinejad B; Farzam F; Bitaraf A; Ghazimoradi MH; Babashah S
    Life Sci; 2021 Jul; 277():119488. PubMed ID: 33862117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competing Endogenous RNA Networks in Glioma.
    Cen L; Liu R; Liu W; Li Q; Cui H
    Front Genet; 2021; 12():675498. PubMed ID: 33995499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of ncRNAs as ceRNAs in Gastric Cancer.
    Ye J; Li J; Zhao P
    Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncoding RNAs in gastric cancer: Research progress and prospects.
    Zhang M; Du X
    World J Gastroenterol; 2016 Aug; 22(29):6610-8. PubMed ID: 27547004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies.
    Yang S; Wang X; Zhou X; Hou L; Wu J; Zhang W; Li H; Gao C; Sun C
    Biomed Pharmacother; 2023 Jun; 162():114698. PubMed ID: 37060661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-coding competing endogenous RNAs in acute myeloid leukemia: biological and clinical implications.
    Zhou Q; Shu X; Chai Y; Liu W; Li Z; Xi Y
    Biomed Pharmacother; 2023 Jul; 163():114807. PubMed ID: 37150037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Breast Cancer Progression by Noncoding RNAs.
    Akshaya RL; Rohini M; Selvamurugan N
    Curr Cancer Drug Targets; 2020; 20(10):757-767. PubMed ID: 32652909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
    PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of ncRNA-associated ceRNA networks in Arabidopsis leaf development.
    Meng X; Zhang P; Chen Q; Wang J; Chen M
    BMC Genomics; 2018 Aug; 19(1):607. PubMed ID: 30103673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of non-coding competing endogenous RNA in hepatocellular carcinoma.
    Xu G; Xu WY; Xiao Y; Jin B; Du SD; Mao YL; Zhang ZT
    Cancer Cell Int; 2020; 20():496. PubMed ID: 33061848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of thyroid cancer: A competing endogenous RNA (ceRNA) point of view.
    Liu Y; Khan S; Li L; Ten Hagen TLM; Falahati M
    Biomed Pharmacother; 2022 Feb; 146():112251. PubMed ID: 34916087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
    Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
    Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of competing endogenous RNA and associated noncoding RNAs in thyroid cancer.
    Bai Q; Pan Z; Nabi G; Rashid F; Liu Y; Khan S
    Am J Cancer Res; 2022; 12(3):961-973. PubMed ID: 35411240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncoding RNA:RNA Regulatory Networks in Cancer.
    Chan JJ; Tay Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
    Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
    Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competing Endogenous RNAs (CeRNAs): Novel Network in Neurological Disorders.
    Tehrani SS; Ebrahimi R; Al-E-Ahmad A; Panahi G; Meshkani R; Younesi S; Saadat P; Parsian H
    Curr Med Chem; 2021; 28(29):5983-6010. PubMed ID: 33334276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Competing Endogenous RNA Regulatory Networks in Vitamin A Deficiency-Induced Congenital Scoliosis by Transcriptome Sequencing Analysis.
    Chen C; Tan H; Bi J; Li Z; Rong T; Lin Y; Sun L; Li X; Shen J
    Cell Physiol Biochem; 2018; 48(5):2134-2146. PubMed ID: 30110682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competing endogenous RNA networks and gastric cancer.
    Guo LL; Song CH; Wang P; Dai LP; Zhang JY; Wang KJ
    World J Gastroenterol; 2015 Nov; 21(41):11680-7. PubMed ID: 26556995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.